With more amino acids being used and fewer amino acids coming in, the theoretical concern is straightforward: adding a glucagon agonist to a GLP-1 should accelerate muscle breakdown
D.OngsiekA.UlbrichL.YeW.JiangZ.et al (2022)
The FDA approved synthetic HGH in 1985 for specific medical conditions, including growth hormone deficiency, Turner syndrome, chronic renal insufficiency, and muscle-wasting disease associated with HIV/AIDS
- Ln 1-2 lt ln vng nch, khong 10 giy n thm thu vo da, sau , bn c th t tin mc ri nh
Clinical data used a gradual escalation schedule to minimise gastrointestinal adverse effects
Dose changes: Fatigue often occurs when starting Mounjaro or after a dose increase, but it usually improves as the body adjusts